These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3587405)

  • 41. Too many treatments for Parkinson's disease: how should they be used?
    Nausieda PA
    WMJ; 2000 Aug; 99(5):4. PubMed ID: 11043061
    [No Abstract]   [Full Text] [Related]  

  • 42. Current therapy of Parkinson's disease.
    Ajax T; Rodnitzky R; Dobson J
    Iowa Med; 1997 Feb; 87(2):71-3. PubMed ID: 9055504
    [No Abstract]   [Full Text] [Related]  

  • 43. Prescribing a better quality of life in Parkinson's disease.
    Noble C
    Community Nurse; 2000 Nov; 6(10):13-4, 17-8. PubMed ID: 11982158
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
    Hälbig TD; Tse W; Olanow CW
    Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug therapy of Parkinson's disease].
    Myllylä V
    Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dopamine receptors and dyskinesias].
    Linazasoro G
    Neurologia; 1998 Apr; 13(4):206-7. PubMed ID: 9608763
    [No Abstract]   [Full Text] [Related]  

  • 47. [Long term experience with Stalevo in Szeged, Hungary].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2009 May; 62(5-6):178-80. PubMed ID: 19579666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B; Montastruc JL
    Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
    [No Abstract]   [Full Text] [Related]  

  • 49. Deprenyl's neuroprotective action remains unresolved.
    van Hilten JJ; Bloem BR; Klaassen AA
    Ann Neurol; 1996 Aug; 40(2):266-7. PubMed ID: 8773615
    [No Abstract]   [Full Text] [Related]  

  • 50. [Freezing of gait is a symptom of Parkinson disease].
    Mezzarobba S; Bandel D; Capus L; Torre P; Moretti R
    Recenti Prog Med; 2004 Sep; 95(9):418-21. PubMed ID: 15473380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ropinirole in the treatment of restless legs].
    Hellebek A; Kampmann JP
    Ugeskr Laeger; 2005 Jun; 167(23):2541; author reply 2541-2. PubMed ID: 16008015
    [No Abstract]   [Full Text] [Related]  

  • 52. Impulse control disorders and dopaminergic drugs.
    Morgan JC; Iyer SS; Sethi KD
    Arch Neurol; 2006 Feb; 63(2):298-9; author reply 299. PubMed ID: 16476826
    [No Abstract]   [Full Text] [Related]  

  • 53. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 54. Rational pharmacotherapy: once-a-day drug dosage.
    Ayd FJ
    Dis Nerv Syst; 1973; 34(7):371-8. PubMed ID: 4782294
    [No Abstract]   [Full Text] [Related]  

  • 55. Parkinson's disease. An overview of treatments and research.
    Tuite PJ
    Minn Med; 2001 May; 84(5):42-7. PubMed ID: 11398632
    [No Abstract]   [Full Text] [Related]  

  • 56. New pharmacological and surgical therapies for Parkinson's disease.
    Nutt JG
    West J Med; 1998 Apr; 168(4):267-8. PubMed ID: 9584671
    [No Abstract]   [Full Text] [Related]  

  • 57. Apomorphine for the acute treatment of "off" episodes in Parkinson's disease.
    Stacy M; Silver D
    Parkinsonism Relat Disord; 2008; 14(2):85-92. PubMed ID: 18083605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new gold standard. Pending drugs could slow progression of Parkinson's.
    Paul KJ
    Contemp Longterm Care; 1999 Feb; 22(2):53. PubMed ID: 10346510
    [No Abstract]   [Full Text] [Related]  

  • 59. [Parkinson disease--planning of long-term therapy].
    Nervenarzt; 1997 Dec; 68(12 Suppl Morbus Par):1-8. PubMed ID: 9439751
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anticholinergic antiparkinson agents].
    Taurand P
    Soins Psychiatr; 1988 Nov; (97):I-II. PubMed ID: 3242060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.